HK1220642A1 - 用於預防和/或治療 型慢性創傷性腦病的方法 - Google Patents

用於預防和/或治療 型慢性創傷性腦病的方法

Info

Publication number
HK1220642A1
HK1220642A1 HK16108896.0A HK16108896A HK1220642A1 HK 1220642 A1 HK1220642 A1 HK 1220642A1 HK 16108896 A HK16108896 A HK 16108896A HK 1220642 A1 HK1220642 A1 HK 1220642A1
Authority
HK
Hong Kong
Prior art keywords
preventing
treating chronic
chronic traumatic
traumatic encephalopathy
encephalopathy
Prior art date
Application number
HK16108896.0A
Other languages
English (en)
Inventor
Robert Vink
Original Assignee
Eustralis Pharmaceuticals Ltd (Trading As Pres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013902455A external-priority patent/AU2013902455A0/en
Application filed by Eustralis Pharmaceuticals Ltd (Trading As Pres filed Critical Eustralis Pharmaceuticals Ltd (Trading As Pres
Publication of HK1220642A1 publication Critical patent/HK1220642A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16108896.0A 2013-07-02 2016-07-26 用於預防和/或治療 型慢性創傷性腦病的方法 HK1220642A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013902455A AU2013902455A0 (en) 2013-07-02 Method for preventing and/or treating chronic traumatic encephalopathy - i
PCT/AU2014/050107 WO2015000032A1 (en) 2013-07-02 2014-07-02 Method for preventing and/or treating chronic traumatic encephalopathy-i

Publications (1)

Publication Number Publication Date
HK1220642A1 true HK1220642A1 (zh) 2017-05-12

Family

ID=52142941

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108896.0A HK1220642A1 (zh) 2013-07-02 2016-07-26 用於預防和/或治療 型慢性創傷性腦病的方法

Country Status (15)

Country Link
US (3) US10729677B2 (zh)
EP (1) EP3016642B1 (zh)
JP (1) JP2016523866A (zh)
KR (1) KR20160030506A (zh)
CN (1) CN105451727B (zh)
AU (2) AU2014286925A1 (zh)
BR (1) BR112015032161A2 (zh)
CA (1) CA2914515C (zh)
HK (1) HK1220642A1 (zh)
IL (1) IL242899B (zh)
MX (1) MX370176B (zh)
RU (1) RU2016103099A (zh)
SG (1) SG11201509932XA (zh)
WO (1) WO2015000032A1 (zh)
ZA (1) ZA201508871B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2914515C (en) * 2013-07-02 2018-12-11 Eustralis Pharmaceuticals Limited (Trading As Pressura Neuro) Method for preventing and/or treating chronic traumatic encephalopathy-i
RU2709614C1 (ru) * 2018-03-06 2019-12-19 Арман Женисович ЛУРЬЕ Способ лечения энцефалопатии
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ514600A0 (en) * 2000-01-18 2000-02-10 James Cook University Brain injury treatment
US20030083345A1 (en) * 2001-07-10 2003-05-01 Torsten Hoffmann Method of treatment and/or prevention of brain, spinal or nerve injury
WO2008067610A1 (en) * 2006-12-08 2008-06-12 Adelaide Research & Innovation Pty Ltd Method for reducing inflammatory responses and inflammation
AU2008278273A1 (en) * 2007-07-19 2009-01-22 Adelaide Research & Innovation Pty Ltd Method for reducing intracranial pressure
US8877768B2 (en) * 2009-09-18 2014-11-04 Chase Pharmaceuticals Corporation Method and composition for treating alzheimer-type dementia
CA2831054C (en) 2013-01-09 2016-08-30 Sapna Life Sciences Corp. Formulations, and methods for their use in treatment of neuropathology and neurodegeneration as a result of traumatic injury
US8992951B2 (en) * 2013-01-09 2015-03-31 Sapna Life Sciences Corporation Formulations, procedures, methods and combinations thereof for reducing or preventing the development, or the risk of development, of neuropathology as a result of trauma
US10501494B2 (en) 2013-04-26 2019-12-10 Creative Bio-Peptides Uses of peptides to treat brain injury and disease
CA2914515C (en) 2013-07-02 2018-12-11 Eustralis Pharmaceuticals Limited (Trading As Pressura Neuro) Method for preventing and/or treating chronic traumatic encephalopathy-i
KR102275705B1 (ko) 2014-07-11 2021-07-09 삼성전자주식회사 웨이퍼 대 웨이퍼 접합 구조

Also Published As

Publication number Publication date
CA2914515A1 (en) 2015-01-08
CN105451727B (zh) 2019-04-23
US20160143881A1 (en) 2016-05-26
BR112015032161A2 (pt) 2017-07-25
US11426384B2 (en) 2022-08-30
AU2019257493A1 (en) 2019-11-21
EP3016642A1 (en) 2016-05-11
SG11201509932XA (en) 2016-01-28
KR20160030506A (ko) 2016-03-18
AU2019257493B2 (en) 2021-04-01
WO2015000032A1 (en) 2015-01-08
US10729677B2 (en) 2020-08-04
CA2914515C (en) 2018-12-11
AU2014286925A1 (en) 2015-12-17
US20220218663A1 (en) 2022-07-14
EP3016642B1 (en) 2019-03-13
CN105451727A (zh) 2016-03-30
RU2016103099A3 (zh) 2018-05-25
EP3016642A4 (en) 2017-03-08
IL242899B (en) 2018-12-31
RU2016103099A (ru) 2017-08-07
MX370176B (es) 2019-12-04
JP2016523866A (ja) 2016-08-12
MX2015017880A (es) 2016-09-22
ZA201508871B (en) 2017-04-26
US20210100773A1 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
HK1221053A1 (zh) 用於保持或改善健康的方法和系統
IL245281A0 (en) Methods and preparations for the treatment of cancer
PT3036247T (pt) Método e sistema para tratar lenhina
TWI563558B (en) Substrate treatment apparatus and substrate treatment method
EP2954376A4 (en) METHODS AND SYSTEMS FOR TREATING FLUID
EP2950884A4 (en) COMPOSITIONS AND METHOD FOR TREATING SURFACES
IL243928A0 (en) Preparations and methods for the treatment of complementary related conditions
IL244118A0 (en) Compounds and methods for the treatment of chronic urticaria
EP2943442A4 (en) SYSTEMS AND METHODS FOR TREATING WASTE WATER
HK1199204A1 (zh) 預防或治療宿醉的組合物
HK1255453A1 (zh) 用於治療白血病的方法和組合物
EP2948138A4 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF SPASTIC HYPERTONIA
HK1221637A1 (zh) 用於預防和/或治療 型慢性創傷性腦病的方法
IL240619B (en) Method and system for water treatment
EP2981339A4 (en) SYSTEMS AND METHOD FOR ADVANCED BETTING
HK1220642A1 (zh) 用於預防和/或治療 型慢性創傷性腦病的方法
EP3065889A4 (en) Composition and method for treating water systems
HK1222323A1 (zh) 用於治療影響表皮的病狀的組合物和方法
EP2969149A4 (en) METHOD AND DEVICE FOR TREATING CANCER
EP3016659A4 (en) Method for preventing and/or treating chronic traumatic encephalopathy-iii
IL246185A0 (en) Methods and compositions for treating dysregulation in systems
GB201311984D0 (en) Methods and compounds for preventing or treating osteoarthritis
EP2971044A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
EP3016658A4 (en) Method for preventing and/or treating chronic traumatic encephalopathy-iv
AU2013902455A0 (en) Method for preventing and/or treating chronic traumatic encephalopathy - i